 |
|||||
|
|||||
|
Innovation through partnership in process development and manufacture
|
|||||
|
19 June: 17:00 - 17:30
|
|||||
|
Dr Youchu Wang, Head of Process R&D, Changzhou Site , STA Pharmaceuticals, a WuXi AppTec Company
|
|||||
|
ABSTRACT
|
|||||
|
Georg Wuitschik (Roche) and Youchou Wang (WuXi STA) will talk about their successful collaboration on RG7907, a drug candidate currently being developed against Hepatitis B. The presentation will focus on what strengths both partners brought to the table and what were the guiding principles for this collaboration.
|
|||||
|
BIOGRAPHY
|
|||||
|
Head of Process R&D, WuXi STA Changzhou Site
Ph.D. in Organic Chemistry, expert in Chemical Development with more than 18 years of experience in Pharmaceutical Industry Youchu is an organic chemist by training. He started his career in Chemical Development at Wyeth (now Pfizer) in 2002 after postdoctoral research in the synthesis of a Natural Product-Bisbenzylisoquinoline. From 2002 to 2008, worked in Chemical Development at Wyeth (now Pfizer) as Process Chemist. In August 2008, joined WuXi STA, a global leading outsourcing company. Currently responsible for Process R&D, WuXi STA Changzhou site, a new integrated CDMO site that includes R&D, Pilot Plant and Commercial Plant in small molecules, peptides and oligonucleotides areas, with a team of more than 400 process chemists. |
|||||
|
COMPANY PROFILE
|
|||||
|
STA Pharmaceuticals, a WuXi AppTec Company
|
|||||
|
STA Pharmaceutical Co., Ltd., a WuXi AppTec company (WuXi STA), is a global leading small molecule pharmaceutical development and manufacturing capability and technology platform company serving the life science industry, with operations in China and the United States. As a premier Contract Development and Manufacturing Organization (CDMO), STA offers our worldwide partners efficient, flexible and high-quality solutions for small molecule Active Pharmaceutical Ingredients (APIs) and finished dosage forms.
|
Learn more about BOS2019
